MedTrace Logo

Comparison of The Severity of Agitation of Sugammadex and Atropine-Nesostigmine in Adenotonsillectomy

NCT03571867 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2018-06-28

No results posted yet for this study

Summary

the use of sugammadex during the reversal of neuromuscular blocking after adenotonsillectomy surgery in pediatric patients would be advantageous in terms of patient comfort and reducing side effects. Thus, we aimed to evaluate the time to extubation, agitation and pain scores in pediatric patients who underwent adenotonsillectomy and awakened with neostigmine and sugammadex in our study.

Conditions

  • The Severity of Agitation in Adenotonsillectomy in Pediatric Patients

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Havva Sayhan, Assis Prof · Sakarya University

Eligibility

Min Age
5 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-09-01
Completion
2018-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571867 on ClinicalTrials.gov